Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 6324-72-7 | MDL No. : | MFCD00075623 |
Formula : | C5H5N5OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | N/A |
M.W : | 183.19 g/mol | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 4.0 |
Molar Refractivity : | 46.3 |
TPSA : | 135.44 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.58 cm/s |
Log Po/w (iLOGP) : | -0.02 |
Log Po/w (XLOGP3) : | -1.64 |
Log Po/w (WLOGP) : | -0.1 |
Log Po/w (MLOGP) : | -1.39 |
Log Po/w (SILICOS-IT) : | 2.21 |
Consensus Log Po/w : | -0.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.5 |
Solubility : | 58.3 mg/ml ; 0.318 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.69 |
Solubility : | 37.1 mg/ml ; 0.202 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.82 |
Solubility : | 2.74 mg/ml ; 0.015 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.99 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Synthesis of Compound (1)Compound (1) was synthesized according to Scheme 1 in the following manner (see also J Am. Chem. Soc. 81 :1898, 1959).To a solution of <strong>[6324-72-7]2-amino-6-hydroxy-8-mercaptopurine</strong> (lg, 5.46 mmol) in 0.5 N NaOH (23.4 mL) was added slowly 4-fluorobenzylbromide (1.13g, 5.97 mmol), and the reaction stirred for 1 hour. At this time, the precipitated solid was filtered. The filtrate was cooled to 0C, acidified with acetic acid (pH ~ 5.0), and the precipitated solid was collected by filtration. The precipitate was again dissolved in 0.5 aqueous NaOH solution (6 niL), washed with EtOAc (2 x 10 mL), and acidified with acetic acid (pH ~5.0). The precipitate was collected by filtration, washed with water (20 mL) and acetone (20 mL), and then dried to give Compound (1) as a pale yellow solid. 1H NMR (300 MHz, CDC13): δ 12.5 (bs, 1H, D20 exchangeable), 10.5 (bs, 1H, D20 exchangeable), 7.41-7.38 (m, 2H), 7.14-7.10 (m, 2H), 6.29 (bs, 2H, D20 exchangeable), 4.37 (s, 2H), Mass (M+H)+ =292 (100), IR (KBr) 3334, 1670, 1344 cm"1. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59.3% | With sodium hydroxide In water at 20℃; for 1h; | 2 General procedure for the preparation of compounds 3-9 and 12-17 General procedure: In a round bottom flask equipped with a stir bar was dissolved 2-amino-6-hydroxy-8-mercaptopurine (1-2 mmol, 1.0 equiv) in aqueous sodium hydroxide (0.4 N, 10 mL) and corresponding phenyl substituted 2-bromoacetophenones (1.25-2.5 mmol,1.25 equiv) dissolved in EtOH (2 mL) was added. The mixtures were stirred for 1 h at room temperature before the solution was neutralized by drop wise addition of HCl (1 N) to yield aprecipitate. The precipitate was collected via vacuum filtration,washed with diethyl ether and verified to be pure via LC-MS and1H NMR. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46.6% | With sodium hydroxide; In water; at 20℃; for 1h; | General procedure: In a round bottom flask equipped with a stir bar was dissolved 2-amino-6-hydroxy-8-mercaptopurine (1-2 mmol, 1.0 equiv) in aqueous sodium hydroxide (0.4 N, 10 mL) and corresponding phenyl substituted 2-bromoacetophenones (1.25-2.5 mmol,1.25 equiv) dissolved in EtOH (2 mL) was added. The mixtures were stirred for 1 h at room temperature before the solution was neutralized by drop wise addition of HCl (1 N) to yield aprecipitate. The precipitate was collected via vacuum filtration,washed with diethyl ether and verified to be pure via LC-MS and1H NMR. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43% | With sodium hydroxide; In water; at 20℃; for 1h; | General procedure: In a round bottom flask equipped with a stir bar was dissolved 2-amino-6-hydroxy-8-mercaptopurine (1-2 mmol, 1.0 equiv) in aqueous sodium hydroxide (0.4 N, 10 mL) and corresponding phenyl substituted 2-bromoacetophenones (1.25-2.5 mmol,1.25 equiv) dissolved in EtOH (2 mL) was added. The mixtures were stirred for 1 h at room temperature before the solution was neutralized by drop wise addition of HCl (1 N) to yield aprecipitate. The precipitate was collected via vacuum filtration,washed with diethyl ether and verified to be pure via LC-MS and1H NMR. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45.3% | With sodium hydroxide; In water; at 20℃; for 1h; | General procedure: In a round bottom flask equipped with a stir bar was dissolved 2-amino-6-hydroxy-8-mercaptopurine (1-2 mmol, 1.0 equiv) in aqueous sodium hydroxide (0.4 N, 10 mL) and corresponding phenyl substituted 2-bromoacetophenones (1.25-2.5 mmol,1.25 equiv) dissolved in EtOH (2 mL) was added. The mixtures were stirred for 1 h at room temperature before the solution was neutralized by drop wise addition of HCl (1 N) to yield aprecipitate. The precipitate was collected via vacuum filtration,washed with diethyl ether and verified to be pure via LC-MS and1H NMR. |
[ 1688-92-2 ]
2,6-Diamino-5-(methylamino)pyrimidin-4(1H)-one
Similarity: 0.87
[ 38365-04-7 ]
2-Amino-5-methyl-5,6,7,8-tetrahydropteridin-4(1H)-one
Similarity: 0.84
[ 51093-31-3 ]
N-(2,6-Diamino-4-oxo-1,4-dihydropyrimidin-5-yl)formamide
Similarity: 0.83
[ 1131-35-7 ]
2-Amino-7,8-dihydropteridine-4,6(1H,5H)-dione
Similarity: 0.82
[ 61693-25-2 ]
5,6-Diamino-2-(methylamino)pyrimidin-4(1H)-one
Similarity: 0.82